Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

Prefazione.

Mirone V.

Urologia. 2018 Jul;85(1_suppl):S3. doi: 10.1177/0391560318773249. No abstract available.

PMID:
30081781
2.

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.

Vartolomei MD, Ferro M, Cantiello F, Lucarelli G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdona S, Verze P, La Rocca R, Borghesi M, Schiavina R, Brunocilla E, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Serretta V, Russo GI, Morgia G, Terracciano D, Musi G, de Cobelli O, Mirone V, Shariat SF.

Clin Genitourin Cancer. 2018 Jul 6. pii: S1558-7673(18)30183-6. doi: 10.1016/j.clgc.2018.07.003. [Epub ahead of print]

PMID:
30077463
3.

Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.

Cimino S, Verze P, Venturino L, Alessio P, Migliara A, Imbimbo C, Mirone V, Russo GI, Morgia G.

Eur Urol Focus. 2018 Jul 12. pii: S2405-4569(18)30162-7. doi: 10.1016/j.euf.2018.06.014. [Epub ahead of print]

PMID:
30007542
4.

An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.

Ferro M, Vartolomei MD, Russo GI, Cantiello F, Farhan ARA, Terracciano D, Cimmino A, Di Stasi S, Musi G, Hurle R, Serretta V, Busetto GM, De Berardinis E, Cioffi A, Perdonà S, Borghesi M, Schiavina R, Cozzi G, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Crisan N, Muto M, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Shariat S, Mirone V, Lucarelli G.

World J Urol. 2018 Jul 10. doi: 10.1007/s00345-018-2397-1. [Epub ahead of print]

PMID:
29992381
5.

High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.

Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Verze P, Battaglia M, Serretta V, Russo GI, Morgia G, Musi G, de Cobelli O, Mirone V, Shariat SF.

Urol Int. 2018;101(1):7-15. doi: 10.1159/000490765. Epub 2018 Jul 4.

PMID:
29975950
6.

Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda.

Magnani T, Bracarda S, D'Angelillo RM, Artibani W, Barni S, Beretta G, Brausi M, Caffo O, Corvò R, Gallucci M, Gunelli R, Mirone V, Novara G, Pinto C, Russi E, Santoni R, Tomirotti M, Volpe A, Conti G, Valdagni R.

Tumori. 2018 Jul 1:300891618784789. doi: 10.1177/0300891618784789. [Epub ahead of print]

PMID:
29974825
7.

L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach.

Cai T, Cocci A, Tiscione D, Puglisi M, Di Maida F, Malossini G, Verze P, Palmieri A, Mirone V, Bjerklund Johansen TE.

Arch Ital Urol Androl. 2018 Jun 30;90(2):97-100. doi: 10.4081/aiua.2018.2.97.

8.

Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy.

Dell'Oglio P, Stabile A, Dias BH, Gandaglia G, Mazzone E, Fossati N, Cucchiara V, Zaffuto E, Mirone V, Suardi N, Mottrie A, Montorsi F, Briganti A.

World J Urol. 2018 Jun 9. doi: 10.1007/s00345-018-2360-1. [Epub ahead of print]

PMID:
29948044
9.

Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study.

Porreca A, Noale M, Artibani W, Bassi PF, Bertoni F, Bracarda S, Conti GN, Corvò R, Gacci M, Graziotti P, Magrini SM, Mirone V, Montironi R, Muto G, Pecoraro S, Ricardi U, Russi E, Tubaro A, Zagonel V, Crepaldi G, Maggi S; Pros-IT CNR study group.

Health Qual Life Outcomes. 2018 Jun 13;16(1):122. doi: 10.1186/s12955-018-0952-5.

10.

Premature Ejaculation Among Italian Men: Prevalence and Clinical Correlates From an Observational, Non-Interventional, Cross-Sectional, Epidemiological Study (IPER).

Verze P, Arcaniolo D, Palmieri A, Cai T, La Rocca R, Franco M, Venturino L, De Sio M, Mirone V.

Sex Med. 2018 Sep;6(3):193-202. doi: 10.1016/j.esxm.2018.04.005. Epub 2018 May 24.

11.

Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study.

Cocci A, Russo GI, Briganti A, Salonia A, Cacciamani G, Capece M, Falcone M, Timpano M, Cito G, Verze P, Giammusso B, Morgia G, Mirone V, Minervini A, Gacci M, Cai T, Serni S, Carini M, Giubilei G, Mondaini N.

BJU Int. 2018 May 23. doi: 10.1111/bju.14410. [Epub ahead of print]

PMID:
29791971
12.

Prostate calcifications: A case series supporting the microbial biofilm theory.

Cai T, Tessarolo F, Caola I, Piccoli F, Nollo G, Caciagli P, Mazzoli S, Palmieri A, Verze P, Malossini G, Mirone V, Bjerklund Johansen TE.

Investig Clin Urol. 2018 May;59(3):187-193. doi: 10.4111/icu.2018.59.3.187. Epub 2018 Apr 4.

13.

Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O.

Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

PMID:
29734177
14.

Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study.

Capece M, Cocci A, Russo G, Cito G, Giubilei G, Cacciamani G, Garaffa G, Falcone M, Timpano M, Tasso G, Sessa F, Campi R, Di Maida F, Cai T, Morelli G, Giammusso B, Verze P, Palmieri A, Ralph D, Mirone V, Mondaini N.

Andrology. 2018 May 7. doi: 10.1111/andr.12497. [Epub ahead of print]

PMID:
29733116
15.

Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.

Cocci A, Russo GI, Salonia A, Cito G, Regis F, Polloni G, Giubilei G, Cacciamani G, Capece M, Falcone M, Greco I, Timpano M, Minervini A, Gacci M, Cai T, Garaffa G, Giammusso B, Arcaniolo D, Mirone V, Mondaini N.

J Sex Med. 2018 May;15(5):716-721. doi: 10.1016/j.jsxm.2018.03.084.

PMID:
29699756
16.

Retroperitoneal Robotic Partial Nephrectomy: Systematic Review and Cumulative Analysis of Comparative Outcomes.

Pavan N, Derweesh I, Hampton LJ, White WM, Porter J, Challacombe BJ, Dasgupta P, Bertolo R, Kaouk J, Mirone V, Porpiglia F, Autorino R.

J Endourol. 2018 Jul;32(7):591-596. doi: 10.1089/end.2018.0211. Epub 2018 May 29.

PMID:
29695171
17.

Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps.

Creta M, Longo N, Imbimbo C, Imperatore V, Mirone V, Fusco F.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S111-S113. doi: 10.21037/tau.2017.12.02. No abstract available.

18.

Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up.

Imperatore V, Creta M, Di Meo S, Buonopane R, Longo N, Fusco F, Spirito L, Imbimbo C, Mirone V.

Arch Ital Urol Androl. 2018 Mar 31;90(1):11-14. doi: 10.4081/aiua.2018.1.11.

19.

Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.

Bianchi L, Schiavina R, Borghesi M, Bianchi FM, Briganti A, Carini M, Terrone C, Mottrie A, Gacci M, Gontero P, Imbimbo C, Marchioro G, Milanese G, Mirone V, Montorsi F, Morgia G, Novara G, Porreca A, Volpe A, Brunocilla E.

Int J Urol. 2018 Jun;25(6):574-581. doi: 10.1111/iju.13565. Epub 2018 Apr 6.

PMID:
29633372
20.

Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?

Giannarini G, Fossati N, Gandaglia G, Cucchiara V, Ficarra V, Mirone V, Montorsi F, Briganti A.

Eur Urol. 2018 Aug;74(2):131-133. doi: 10.1016/j.eururo.2018.03.021. Epub 2018 Apr 4.

PMID:
29625757
21.
22.

Seminal vesicle abscess causing unilateral hydroureteronephrosis: A case report.

Imperatore V, Creta M, Di Meo S, Buonopane R, Spirito L, Mirone V.

Arch Ital Urol Androl. 2017 Dec 31;89(4):321-322. doi: 10.4081/aiua.2017.4.321.

23.

Incidentally discovered pelvic paraganglioma: A case report.

Imperatore V, Creta M, Di Meo S, Buonopane R, Spirito L, Fusco F, Longo N, Forte NR, Mirone V.

Arch Ital Urol Androl. 2017 Dec 31;89(4):319-320. doi: 10.4081/aiua.2017.4.319.

24.

Risk factors for benign prostatic enlargement: The role of lifestyle habits at younger age. The #Controllati2017 initiative study group.

Mirone V, Carrieri G, Morgia G, Carmignani L, Vespasiani G, Parazzini F, Artibani W.

Arch Ital Urol Androl. 2017 Dec 31;89(4):253-258. doi: 10.4081/aiua.2017.4.253.

25.

The Potential Role of MicroRNAs as Biomarkers in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Greco F, Inferrera A, La Rocca R, Navarra M, Casciaro M, Grosso G, Gangemi S, Ficarra V, Mirone V.

Eur Urol Focus. 2018 Feb 2. pii: S2405-4569(18)30009-9. doi: 10.1016/j.euf.2018.01.008. [Epub ahead of print] Review.

PMID:
29398458
26.

Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.

Siracusano S, D'Elia C, Cerruto MA, Saleh O, Serni S, Gacci M, Ciciliato S, Simonato A, Porcaro A, DE Marco V, Talamini R, Toffoli L, Visalli F, Niero M, Lonardi C, Imbimbo C, Verze P, Mirone V, Racioppi M, Iafrate M, Cacciamani G, DE Marchi D, Bassi P, Artibani W.

In Vivo. 2018 Jan-Feb;32(1):139-143.

27.

Effectiveness and Safety of Oro-Dispersible Sildenafil in a New Film Formulation for the Treatment of Erectile Dysfunction: Comparison Between Sildenafil 100-mg Film-Coated Tablet and 75-mg Oro-Dispersible Film.

Cocci A, Capece M, Cito G, Russo GI, Falcone M, Timpano M, Rizzo M, Della Camera PA, Morselli S, Campi R, Sessa F, Cacciamani G, Minervini A, Gacci M, Mirone V, Morelli G, Mondaini N, Polloni G, Serni S, Natali A.

J Sex Med. 2017 Dec;14(12):1606-1611. doi: 10.1016/j.jsxm.2017.10.066. Epub 2017 Nov 16.

PMID:
29153580
28.

Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR.

Gacci M, Noale M, Artibani W, Bassi PF, Bertoni F, Bracarda S, Conti GN, Corvò R, Graziotti P, Magrini SM, Mirone V, Montironi R, Muto G, Pecoraro S, Porreca A, Ricardi U, Russi E, Tubaro A, Zagonel V, Crepaldi G, Maggi S; Pros-IT CNR study group.

Eur Urol Focus. 2017 Oct;3(4-5):321-324. doi: 10.1016/j.euf.2017.10.009. Epub 2017 Nov 13.

PMID:
29146557
29.

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study.

Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Boccasile S, Ditonno P, Chiodini P, Verze P, Mirone V, Schips L.

BMC Cancer. 2017 Nov 10;17(1):753. doi: 10.1186/s12885-017-3755-x.

30.

Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study.

Cai T, Pisano F, Nesi G, Magri V, Verze P, Perletti G, Gontero P, Mirone V, Bartoletti R.

Investig Clin Urol. 2017 Nov;58(6):460-467. doi: 10.4111/icu.2017.58.6.460. Epub 2017 Oct 31.

31.

Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center.

Vartolomei MD, Matei DV, Renne G, Tringali VM, Crisan N, Musi G, Mistretta FA, Russo A, Cozzi G, Cordima G, Luzzago S, Cioffi A, Di Trapani E, Catellani M, Delor M, Bottero D, Imbimbo C, Mirone V, Ferro M, de Cobelli O.

Eur Urol Focus. 2017 Oct 27. pii: S2405-4569(17)30242-0. doi: 10.1016/j.euf.2017.10.005. [Epub ahead of print]

PMID:
29111154
32.

Standard vs. anatomical 180-W GreenLight laser photoselective vaporization of the prostate: a propensity score analysis.

Cindolo L, De Nunzio C, Greco F, Destefanis P, Bergamaschi F, Ferrari G, Fasolis G, Palmieri F, Divan C, Oriti R, Ruggera L, Tubaro A, Dadone C, De Rienzo G, Frattini A, Mirone V, Schips L; Members of Green Laser Italian Group.

World J Urol. 2018 Jan;36(1):91-97. doi: 10.1007/s00345-017-2106-5. Epub 2017 Nov 1.

PMID:
29090340
33.

The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.

Cianferotti L, Bertoldo F, Carini M, Kanis JA, Lapini A, Longo N, Martorana G, Mirone V, Reginster JY, Rizzoli R, Brandi ML.

Oncotarget. 2017 May 18;8(43):75646-75663. doi: 10.18632/oncotarget.17980. eCollection 2017 Sep 26. Review.

34.

New Hybrid Mini-laparoendoscopic Single-site Partial Nephrectomy With Early Unclamped Technique for Renal Tumors With Intermediate PADUA Score (IDEAL Phase 2a).

Springer C, Kawan F, La Rocca R, Mohammed N, Fornara P, Mirone V, Greco F.

Urology. 2018 Jan;111:104-109. doi: 10.1016/j.urology.2017.09.017. Epub 2017 Oct 9.

PMID:
29024738
35.

Giant primary scrotal lipoma: A case report.

Creta M, De Stefano G, Buonopane R, Barba C, Di Meo S, Imperatore V, Imbimbo C, Mirone V.

Arch Ital Urol Androl. 2017 Oct 3;89(3):243-244. doi: 10.4081/aiua.2017.3.243.

36.

Male Ageing or "Mencession": Let's Try to Reclaim the Myth of the Strongest Sex.

Mirone V, Verze P, Califano G, La Rocca R.

Eur Urol Focus. 2017 Oct;3(4-5):311-312. doi: 10.1016/j.euf.2017.09.004. Epub 2017 Sep 15. No abstract available.

PMID:
28927727
37.

A prospective randomized comparison among SWL, PCNL and RIRS for lower calyceal stones less than 2 cm: a multicenter experience : A better understanding on the treatment options for lower pole stones.

Bozzini G, Verze P, Arcaniolo D, Dal Piaz O, Buffi NM, Guazzoni G, Provenzano M, Osmolorskij B, Sanguedolce F, Montanari E, Macchione N, Pummer K, Mirone V, De Sio M, Taverna G.

World J Urol. 2017 Dec;35(12):1967-1975. doi: 10.1007/s00345-017-2084-7. Epub 2017 Sep 5.

PMID:
28875295
38.

Scrotal Abscess Drained by Iatrogenic Urethral Fistula in an Adult Diabetic Male.

Stizzo M, Arcaniolo D, Quattrone C, Balsamo R, Terribile M, Manfredi C, Mirone V, Verze P, De Sio M.

Case Rep Urol. 2017;2017:9820245. doi: 10.1155/2017/9820245. Epub 2017 Jul 17.

39.

Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.

Mirone V, Imbimbo C, Arcaniolo D, Franco M, La Rocca R, Venturino L, Spirito L, Creta M, Verze P.

World J Urol. 2017 Dec;35(12):1857-1862. doi: 10.1007/s00345-017-2074-9. Epub 2017 Aug 5.

PMID:
28780740
40.

β3 adrenergic receptor activation relaxes human corpus cavernosum and penile artery through a hydrogen sulfide/cGMP-dependent mechanism.

Mitidieri E, Tramontano T, Gurgone D, Imbimbo C, Mirone V, Fusco F, Cirino G, d'Emmanuele di Villa Bianca R, Sorrentino R.

Pharmacol Res. 2017 Oct;124:100-104. doi: 10.1016/j.phrs.2017.07.025. Epub 2017 Jul 29.

PMID:
28760490
41.

Minilaparoendoscopic Single-site Pyeloplasty: The Best Compromise Between Surgeon's Ergonomy and Patient's Cosmesis (IDEAL Phase 2a).

Greco F, Pini G, Alba S, Altieri VM, Verze P, Mirone V.

Eur Urol Focus. 2016 Aug;2(3):319-326. doi: 10.1016/j.euf.2015.09.001. Epub 2015 Oct 3.

PMID:
28723379
42.

Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.

Favilla V, Russo GI, Zucchi A, Siracusa G, Privitera S, Cimino S, Madonia M, Cai T, Cavallini G, Liguori G, D'Achille G, Silvani M, Franco G, Verze P, Palmieri A, Torrisi B, Mirone V, Morgia G.

Andrology. 2017 Jul;5(4):771-775. doi: 10.1111/andr.12368.

43.

A case of highly aggressive anaplastic seminoma of the testis presenting as fungating scrotal lesion.

Creta M, Mirone V, Di Meo S, Buonopane R, Longo N, Fusco F, Forte NR, Imperatore V.

Arch Ital Urol Androl. 2017 Jun 30;89(2):158-159. doi: 10.4081/aiua.2017.2.158.

44.

A rare case of male pelvic squamous cell carcinoma of unknown primary origin presenting as perineal abscess and urethral stenosis.

Creta M, Mirone V, Di Meo S, Buonopane R, Longo N, Fusco F, Forte NR, Imperatore V.

Arch Ital Urol Androl. 2017 Jun 30;89(2):154-155. doi: 10.4081/aiua.2017.2.154.

45.

The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8.

Cai T, Verze P, La Rocca R, Palmieri A, Tiscione D, Luciani LG, Mazzoli S, Mirone V, Malossini G.

World J Mens Health. 2017 Aug;35(2):120-128. doi: 10.5534/wjmh.2017.35.2.120. Epub 2017 Apr 30.

46.

Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers.

Terracciano D, Ferro M, Terreri S, Lucarelli G, D'Elia C, Musi G, de Cobelli O, Mirone V, Cimmino A.

Transl Res. 2017 Jun;184:108-117. doi: 10.1016/j.trsl.2017.03.005. Epub 2017 Apr 7. Review.

PMID:
28438520
47.

The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials.

Cai T, Verze P, La Rocca R, Anceschi U, De Nunzio C, Mirone V.

BMC Urol. 2017 Apr 21;17(1):32. doi: 10.1186/s12894-017-0223-5. Review.

48.

Urinary symptoms and sexual dysfunction among Italian men: The results of the #Controllati survey.

Mirone V, Carone R, Carrieri G, Costantini E, Morgia G, Ludovico GM, Villari D, Parazzini F.

Arch Ital Urol Androl. 2017 Mar 31;89(1):75-80. doi: 10.4081/aiua.2017.1.75.

49.

Daidzein plus isolase associated with zinc improves clinical symptoms and quality of life in patients with LUTS due to benign prostatic hyperplasia: Results from a phase I-II study.

Tiscione D, Gallelli L, Tamanini I, Luciani LG, Verze P, Palmieri A, Mirone V, Bartoletti R, Malossini G, Cai T.

Arch Ital Urol Androl. 2017 Mar 31;89(1):12-16. doi: 10.4081/aiua.2017.1.12.

50.

The Role of the Hydrogen Sulfide Pathway in Male and Female Urogenital System in Health and Disease.

d'Emmanuele di Villa Bianca R, Fusco F, Mirone V, Cirino G, Sorrentino R.

Antioxid Redox Signal. 2017 Oct 1;27(10):654-668. doi: 10.1089/ars.2017.7079. Epub 2017 May 19. Review.

PMID:
28398118

Supplemental Content

Loading ...
Support Center